Cleared Abbreviated

K070559 - POLYMAP PWR-08-03

K070559 is an FDA 510(k) clearance for POLYMAP PWR-08-03, manufactured by Polymap Wireless. The device is a Class 2 Chemistry device with product code NBW cleared through the Abbreviated 510(k) pathway after a 122-day FDA review.

K070559 · Polymap Wireless · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2007
Decision
122d
Days
Class 2
Risk

K070559 is an FDA 510(k) clearance for the POLYMAP PWR-08-03. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Polymap Wireless (Tucson, US). The FDA issued a Cleared decision on June 29, 2007 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Polymap Wireless devices

FDA 510(k) Submission Details - K070559

510(k) Number K070559 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 2007
Decision Date June 29, 2007
Days to Decision 122 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 88d · This submission: 122d
Pathway characteristics
Standards-based clearance path.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 310
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K070559.
ADVOCATE REDI-CODE BLOOD GLUCOSE MONITORING SYSTEM, MODELS TD-4223E
K072039 · Taidoc Technology Corporation · Oct 2007
REVOLUTION TD-4229 BLOOD GLUCOSE MONITORING SYSTEM
K072489 · Taidoc Technology Corporation · Sep 2007
PTS PANELS CHOL+HDL+GLU PANEL TEST STRIPS
K071507 · Polymer Technology Systems, Inc. · Sep 2007
CLEVER CHEK HEALTH CARE SYSTEM SOFTWARE, VERSION 1.0
K070941 · Taidoc Technology Corporation · Jun 2007
NOVA MAX BLOOD GLUCOSE MONITOR SYSTEM, 90001,90002
K070255 · Nova Biomedical Corp. · Jun 2007
ACCU-CHEK PERFORMA SYSTEM
K070585 · Roche Diagnostics Corp. · May 2007